Company profile for Verrica Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Verrica Pharmaceuticals Inc. is a medical dermatology company committed to the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases. We seek to understand the patient journey and the healthcare provider landscape when developing our clinical programs, with the goal of delivering treatment solutions for millions of underserved patients. Headquartered in West ...
Verrica Pharmaceuticals Inc. is a medical dermatology company committed to the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases. We seek to understand the patient journey and the healthcare provider landscape when developing our clinical programs, with the goal of delivering treatment solutions for millions of underserved patients. Headquartered in West Chester, Pennsylvania, Verrica was founded in 2013. We are led by a seasoned management team with extensive pharmaceutical industry experience ranging from drug development through commercialization.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10 North High Street Suite 200 West Chester, PA 19380
Telephone
Telephone
484-453-3300
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/24/3193428/0/en/Verrica-Pharmaceuticals-Announces-Private-Placement-Financing-of-50-Million-to-Retire-Debt-and-Extend-Cash-Runway.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3184504/0/en/Verrica-Pharmaceuticals-Presents-New-Data-on-VP-315-from-its-Phase-2-Clinical-Trial-in-Basal-Cell-Carcinoma-at-the-40th-Society-for-Immunotherapy-of-Cancer-Annual-Meeting.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/10/20/3169756/0/en/Verrica-Pharmaceuticals-Receives-Positive-Feedback-from-the-European-Medicines-Agency-EMA-Supporting-a-Clear-Regulatory-Path-Forward-to-File-for-Approval-of-YCANTH-in-the-European-.html

GLOBENEWSWIRE
20 Oct 2025

https://www.globenewswire.com/news-release/2025/10/07/3162943/0/en/Verrica-Pharmaceuticals-to-Present-New-Data-on-VP-315-from-its-Phase-2-Trial-in-Basal-Cell-Carcinoma-BCC-at-the-40th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html

GLOBENEWSWIRE
07 Oct 2025

https://www.globenewswire.com/news-release/2025/09/19/3153129/0/en/Verrica-Pharmaceuticals-Announces-That-Development-Partner-Torii-Pharmaceutical-Receives-Approval-for-YCANTH-TO-208-in-Japan-for-the-Treatment-of-Molluscum-Contagiosum.html

GLOBENEWSWIRE
19 Sep 2025

https://www.globenewswire.com/news-release/2025/09/02/3142484/0/en/Verrica-Pharmaceuticals-to-Participate-in-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

GLOBENEWSWIRE
02 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty